Publications by authors named "Mark Krailo"

100Publications

Developing and Using a Data Commons for Understanding the Molecular Characteristics of Germ Cell Tumors.

Methods Mol Biol 2021 ;2195:263-275

Department of Clinical Sciences, Quantitative Biomedical Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-0716-0860-9_17DOI Listing
January 2021

Reply to S.A. Upadhyaya.

J Clin Oncol 2020 Oct 30;38(28):3353-3354. Epub 2020 Jul 30.

Alyssa T. Reddy, MD, University of California San Francisco, CA; Mark D. Krailo, PhD, Keck School of Medicine, University of Southern California, Los Angeles, CA; Allen B. Buxton, MS, Children's Oncology Group, Monrovia, CA; Douglas R. Strother, MD, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Annie Huang, MD, PhD, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, ON, Canada; Tianni Zhou, PhD, California State University at Long Beach, Long Beach, CA; Alexander R. Judkins, MD, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA; Peter C. Burger, MD, Johns Hopkins University, Baltimore, MD; Ian F. Pollack, MD, University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh, Pittsburgh, PA; Chris Williams-Hughes, BS, Children's Oncology Group, Monrovia, CA; Maryam Fouladi, MD, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Ben Ho, MSc, Hospital for Sick Children, Toronto, ON, Canada; Claire M. Mazewski, MD, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA; Victor A. Lewis, MD, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Louis-Gilbert Vezina, MD, The George Washington University School Medicine and Health Sciences, Washington, DC; Timothy N. Booth, MD, University of Texas Southwestern, Dallas, TX; and Anita Mahajan, MD, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.01573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526718PMC
October 2020

Information fraction estimation based on the number of events within the standard treatment regimen.

Biom J 2020 Jul 6. Epub 2020 Jul 6.

Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bimj.201900236DOI Listing
July 2020

Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial.

Clin Trials 2019 12 3;16(6):599-609. Epub 2019 Oct 3.

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774519875969DOI Listing
December 2019

Rejoinder.

Clin Trials 2019 12 3;16(6):613-615. Epub 2019 Oct 3.

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774519875971DOI Listing
December 2019

Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII).

Eur J Cancer 2019 09 12;118:49-57. Epub 2019 Jul 12.

Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.05.001DOI Listing
September 2019

Improvements to the Escalation with Overdose Control design and a comparison with the restricted Continual Reassessment Method.

Pharm Stat 2019 11 25;18(6):659-670. Epub 2019 Jun 25.

Department of Preventive Medicine, Keck School of Medicine, The University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pst.1955DOI Listing
November 2019

A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.

Pediatr Blood Cancer 2019 02 30;66(2):e27524. Epub 2018 Oct 30.

Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27524DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501793PMC
February 2019

Klinefelter syndrome in males with germ cell tumors: A report from the Children's Oncology Group.

Cancer 2018 10 6;124(19):3900-3908. Epub 2018 Oct 6.

Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31667DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241518PMC
October 2018

Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group.

Pediatr Blood Cancer 2019 01 25;66(1):e27444. Epub 2018 Sep 25.

Center for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249072PMC
January 2019

Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials.

Cancer Med 2018 May 30. Epub 2018 May 30.

Division of Hematology, Oncology, and Blood and Bone Marrow Transplantation, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051159PMC
May 2018

Family history of cancer in children and adolescents with germ cell tumours: a report from the Children's Oncology Group.

Br J Cancer 2018 01 24;118(1):121-126. Epub 2017 Oct 24.

Dana-Farber/ Boston Children's Cancer and Blood Disorders Center, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.358DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765220PMC
January 2018

Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.

J Clin Oncol 2017 Oct 11;35(30):3465-3473. Epub 2017 Sep 11.

Allison F. O'Neill and Christopher B. Weldon, Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School, Boston, MA; Alexander J. Towbin and Greg M. Tiao, Cincinnati Children's Hospital, Cincinnati, OH; Mark D. Krailo, University of Southern California Keck School of Medicine, Los Angeles; Caihong Xia and Yun Gao, Children's Oncology Group, Monrovia; Marcio Malogolowkin, University of California Davis Comprehensive Cancer Center, Sacramento, CA; M. Beth McCarville, Wayne L. Furman, and Carlos Rodriguez-Galindo, St Jude Children's Research Hospital; Max R. Langham Jr, Le Bonheur Children's Hospital and University of Tennessee, Memphis; Howard M. Katzenstein, Vanderbilt University School of Medicine, Monroe Carell Jr Children's Hospital, Nashville, TN; Rebecka L. Meyers, Primary Children's Hospital and University of Utah, Salt Lake City, UT; Eugene D. McGahren, University of Virginia Children's Hospital and University of Virginia, Charlottesville, VA; Stephen P. Dunn, duPont Hospital for Children and Thomas Jefferson University, Philadelphia; Sarangarajan Ranganathan, Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, PA; and Milton J. Finegold, Baylor College of Medicine, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.5654DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648177PMC
October 2017

The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma.

Pediatr Blood Cancer 2017 Dec 24;64(12). Epub 2017 May 24.

Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26659DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695860PMC
December 2017

Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children's Oncology Group.

J Expo Sci Environ Epidemiol 2017 07 8;27(4):359-364. Epub 2017 Mar 8.

Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jes.2017.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478474PMC
July 2017

Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.

J Clin Oncol 2017 Apr 27;35(11):1203-1210. Epub 2017 Feb 27.

Furqan Shaikh, The Hospital for Sick Children, University of Toronto, Toronto, Canada; John W. Cullen, Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, CO; Thomas A. Olson, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA; Farzana Pashankar, Yale University School of Medicine, New Haven, CT; Marcio H. Malogolowkin, University of California Davis Comprehensive Cancer Center, Sacramento; Doojduen Villaluna and Mark Krailo, Children's Oncology Group, Monrovia; Mark Krailo, University of Southern California, Los Angeles, CA; James F. Amatruda, University of Texas Southwestern Medical Center and Children's Medical Center Dallas, Dallas, TX; Deborah F. Billmire and Frederick J. Rescorla, Riley Hospital for Children, Indianapolis, IN; Rachel A. Egler and Jonathan H. Ross, Rainbow Babies and Children's Hospital, Cleveland, OH; Bryan J. Dicken, Stollery Children's Hospital, and University of Alberta Hospital, Edmonton, Alberta, Canada; Marc Schlatter, Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, MI; Carlos Rodriguez-Galindo, St Jude Children's Research Hospital, Memphis, TN; and A. Lindsay Frazier, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.6544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455599PMC
April 2017

Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation.

Br J Cancer 2017 01 22;116(1):21-27. Epub 2016 Nov 22.

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220147PMC
January 2017

A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG.

Cancer 2017 Jan 16;123(1):144-154. Epub 2016 Aug 16.

Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161556PMC
January 2017

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.

J Clin Oncol 2016 09 11;34(25):3031-8. Epub 2016 Jul 11.

Joanne P. Lagmay, Shands Hospital for Children, University of Florida, Gainesville, FL; Mark D. Krailo and Ha Dang, University of Southern California, Los Angeles; and Children's Oncology Group, Monrovia; Theodore Zwerdling, Jonathan Jaques Children's Cancer Center, Miller Children's and Women's Hospital, Long Beach, CA; AeRang Kim, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC; Douglas S. Hawkins, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA; Orren Beaty III, Zeiss Children's Cancer Center, Mission Hospitals, Asheville, NC; Brigitte C. Widemann, National Institutes of Health Clinical Center, Bethesda, MD; Lisa Bomgaars and Susan M. Blaney, Baylor College of Medicine/Texas Children's Cancer Center, Houston; Anne-Marie Langevin, University of Texas Health Science Center at San Antonio, San Antonio, TX; Holcombe E. Grier and Katherine A. Janeway, Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center, Boston, MA; Brenda Weigel, University of Minnesota, Minneapolis, MN; and Richard Gorlick, The Albert Einstein College of Medicine of Yeshiva University, The Children's Hospital at Montefiore, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.5381DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012712PMC
September 2016

Can Big Data Shed Light on the Origins of Pediatric Cancer?

Pediatrics 2016 06;137(6)

Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://pediatrics.aappublications.org/cgi/doi/10.1542/peds.2
Publisher Site
http://dx.doi.org/10.1542/peds.2016-0983DOI Listing
June 2016

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

Cancer Res 2016 07 19;76(13):4002-11. Epub 2016 Apr 19.

Department of Pediatrics, Baylor College of Medicine, Houston, Texas. Dan L. Duncan Cancer Center Baylor College of Medicine, Houston, Texas. Texas Children's Hematology and Oncology Centers, Texas Children's Hospital, Houston, Texas. Program of Structural and Computational Biology and Molecular Biophysics, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-3189DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930684PMC
July 2016

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.

Neuro Oncol 2016 10 22;18(10):1442-50. Epub 2016 Mar 22.

Departments of Pediatrics (R.I.J.), Pathology (R.L.H.) and Neurosurgery (I.F.P.), University of Pittsburgh School of Medicine, Pittsburgh, PA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland (K.J.C.); Children's Oncology Group, Operations Office, Monrovia, California (A.B., M.D.K.); Department of Preventive Medicine, University of Southern California, Los Angeles, California (M.D.K, S.P.E.); Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland (P.C.B.); Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York (M.K.R.); Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia (D.J.B.); Department of Mathematics and Statistics, California State University, Long Beach, California (T.Z.); Maurer Family Cancer Care Center, Bowling Green, Ohio (R.S.L.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035517PMC
October 2016

Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group Report.

Sarcoma 2015 5;2015:927123. Epub 2015 Oct 5.

Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90027, USA ; Children's Oncology Group Statistics, Monrovia, CA 91016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/927123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609872PMC
October 2015

Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group.

Pediatr Blood Cancer 2016 Feb 16;63(2):370-1. Epub 2015 Sep 16.

Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25754DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830388PMC
February 2016

Rare Tumors in Children: Progress Through Collaboration.

J Clin Oncol 2015 Sep 24;33(27):3047-54. Epub 2015 Aug 24.

Alberto S. Pappo and Wayne L. Furman, St Jude Children's Research Hospital, Memphis, TN; Kris A. Schultz, Children's Hospital of Minnesota, Minneapolis, MN; Andrea Ferrari, Instituto Nazionale Tumori, Milano, Italy; Lee Helman, National Cancer Institute Center for Cancer Research, Bethesda, MD; and Mark D. Krailo, Keck School of Medicine, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.3632DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979197PMC
September 2015

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.

J Clin Oncol 2015 Sep 24;33(27):3018-28. Epub 2015 Aug 24.

Thomas A. Olson, Emory University, Atlanta, GA; Matthew J. Murray and James C. Nicholson, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, United Kingdom; Carlos Rodriguez-Galindo and A. Lindsay Frazier, Boston Children's Hospital, Boston; Carlos Rodriguez-Galindo, A. Lindsay Frazier, and Christopher Sweeney, Dana-Farber Cancer Institute, Boston, MA; Deborah F. Billmore, Riley Hospital for Sick Children, Indianapolis, IN; Mark D. Krailo and Ha M. Dang, University of Southern California, Los Angeles, CA; James F. Amatruda, University of Texas Southwestern Medical Center and Children's Medical Center, Dallas; David M. Gershenson, University of Texas MD Anderson Cancer Center, Houston, TX; Claire M. Thornton, Royal Victoria Hospital, Belfast, United Kingdom; G. Suren Arul, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom; Sara J. Stoneham, University College London Hospitals NHS Foundation Trust, London, United Kingdom; Farzana Pashankar, Yale University School of Medicine, New Haven, CT; Daniel Stark, University of Leeds, Leeds, United Kingdom; Furqan Shaikh, The Hospital for Sick Children, Toronto; Allan Covens, University of Toronto, Toronto, Ontario, Canada; Jean Hurteau, University of Chicago Pritzker School of Medicine, Chicago, IL; Sally P. Stenning, Medical Research Council, London, United Kingdom; Darren R. Feldman, Memorial Sloan Kettering Cancer Center, New York, NY; Peter S. Grimison, Sydney Cancer Center, Sydney, New South Wales, Australia; Robert A. Huddart, Institute of Cancer Research and Royal Marsden Hospital, Surrey, United Kingdom; Thomas Powles, Barts Cancer Institute, London, United Kingdom; Luiz Fernando Lopes, Barretos Pediatric Cancer Center, São Paulo, Brazil; Simone dos Santos Agular, Centro Infantil Boldrini, Campinas, Brazil; Girish Chinnaswamy, Tata Memorial Hospital, Mumbai, India; Sahar Khaleel and Sherif Abouelnaga, Children's Cancer Hospital, Cairo, Egypt; and Jul

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.5337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979195PMC
September 2015

Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group.

J Immunother 2015 Sep;38(7):299-305

*Department of Pediatric Hematology-Oncology, Children's National Medical Center, George Washington University School of Medicine and Public Health, Washington, DC †Clinical Investigations Branch, Cancer Therapy Evaluation Program, NCI, Bethesda ¶¶Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ‡Keck School of Medicine, University of Southern California ¶Division of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles §Children's Oncology Group, Arcadia ‡‡Department of Pediatrics, City of Hope National Medical Center, Duarte, CA ∥Department of Biostatistics and Bioinformatics, Emory University ∥∥Aflac Cancer and Blood Disorder Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA #Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN **Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA ††Pediatric Hematology-Oncology, C.S. Mott Children's Hospital, Ann Arbor, MI §§Division of Pediatrics, Children's Cancer Hospital at the University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536569PMC
September 2015

Identification of Discrete Prognostic Groups in Ewing Sarcoma.

Pediatr Blood Cancer 2016 Jan 10;63(1):47-53. Epub 2015 Aug 10.

Department of Pediatrics, University of California, San Francisco School of Medicine, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25709DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011751PMC
January 2016

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

J Clin Oncol 2015 Jul 1;33(20):2279-87. Epub 2015 Jun 1.

Stefan S. Bielack, Klinikum Stuttgart-Olgahospital, Stuttgart; Mathias Werner, Helios Klinikum Emil von Behring; Per-Ulf Tunn, Helios Klinikum Berlin-Buch, Berlin; Knut Helmke, Altonaer Kinderkrankenhaus, Hamburg; Heribert Jürgens, Gabriele Calaminus, Joachim Gerss, and Trude Butterfass-Bahloul, Universitätsklinikum Münster, Münster; Peter Reichardt, Klinik für Interdisziplinäre Onkologie, Bad Saarow, Germany; Sigbjørn Smeland and Kirsten Sundby Hall, Oslo University Hospital; Kirsten Sundby Hall, Norwegian Radium Hospital, Oslo, Norway; Jeremy S. Whelan, University College London Hospitals; Gordana Jovic, Jane M. Hook, and Matthew R. Sydes, University College London; Beatrice Seddon and Maria Michelagnoli, University College Hospital, London; Bernadette Brennan, Christie Hospital and Royal Manchester Children's Hospital, Manchester; Susan Picton, Leeds University Hospital, Leeds, United Kingdom; Neyssa Marina, Stanford University Medical Center; Claudia Deffenbaugh, Lucille Salter Packard Children's Hospital, Palo Alto; Mark D. Krailo, Children's Oncology Group, Arcadia, CA; Mark Gebhardt and Allen Goorin, Dana-Farber Cancer Institute; Mark Gebhardt and Lisa A. Teot, Children's Hospital Boston, Boston, MA; Zsuzsanna Pápai, National Medical Center, Budapest, Hungary; James Meyer, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Helen Nadel, British Columbia Children's Hospital and University of British Columbia, Vancouver, British Columbia; Mark Bernstein, Dalhousie University, Halifax, Nova Scotia, Canada; R. Lor Randall, University of Utah, Salt Lake City, UT; Rajaram Nagarajan, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; G. Douglas Letson, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL; Daniel Baumhoer, Universitätsspital Basel; Thomas Kühne, University Children's Hospital Basel, Basel, Switzerland; Leo Kager, St Anna's Children Hospital; Reinhard Windhager, Medica

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.0734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486345PMC
July 2015

A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†.

Neuro Oncol 2015 Aug 7;17(8):1132-8. Epub 2015 Apr 7.

Texas Children's Cancer and Hematology Centers, Department of Pathology, Baylor College of Medicine, Houston, Texas (M.C., A.A., C.L.); Department of Preventive Medicine, University of Southern California, Los Angeles, California (S.P.E., M.K.); University of Texas Southwestern Medical Center, Dallas, Texas (M.M.); Children's National Medical Center, Washington DC (R.P.); St Jude Children's Research Hospital, Memphis, Tennessee (A.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490875PMC
August 2015

A summary of the osteosarcoma banking efforts: a report from the Children's Oncology Group and the QuadW Foundation.

Pediatr Blood Cancer 2015 Mar 8;62(3):450-5. Epub 2014 Dec 8.

Children's Cancer and Blood Disorders Program, Randall Children's Hospital, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304398PMC
March 2015

Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status.

Epigenetics 2015 23;10(1):31-9. Epub 2015 Jan 23.

a Division of Pediatric Hematology/Oncology; Children's Hospital at Montefiore; Albert Einstein College of Medicine ; Bronx , NY USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.4161/15592294.2014.98
Publisher Site
http://dx.doi.org/10.4161/15592294.2014.989084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622015PMC
June 2016

Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group.

Pediatr Blood Cancer 2015 May 2;62(5):759-65. Epub 2014 Dec 2.

Department of Orthopedics, University of Utah, Salt Lake City, Utah; Center for Children's Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376595PMC
May 2015

Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.

J Clin Oncol 2015 Jan 1;33(2):195-201. Epub 2014 Dec 1.

A. Lindsay Frazier and Carlos Rodriguez-Galindo, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Juliet P. Hale, Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust, Newcastle upon Tyne; Matthew J. Murray and James C. Nicholson, Cambridge University Hospitals NHS Foundation Trust; Matthew J. Murray, University of Cambridge, Cambridge; Claire Thornton, Royal Victoria Hospital, Belfast Health Trust, Belfast; G. Suren Arul, Birmingham Children's Hospital NHS Foundation Trust, Birgmingham; Sara Stoneham, Children's and Young Persons Cancer Services, University College London Hospital Trusts, London, United Kingdom; Ha Dang, Children's Oncology Group; Mark Krailo, University of Southern California, Los Angeles, CA; Thomas Olson, Children's Healthcare of Atlanta, Emory University, Atlanta, GA; James F. Amatruda, University of Texas Southwestern Medical Center and Children's Medical Center Dallas, Dallas, TX; Deborah Billmire, Riley Hospital for Children, Indianapolis, IN; Furqan Shaikh, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; and Farzana Pashankar, Yale Cancer Center, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.3369DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279239PMC
January 2015

Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.

Cancer 2015 Mar 11;121(5):697-707. Epub 2014 Nov 11.

Department of Nursing, School of Nursing and Health Studies, Georgetown University, Washington, District of Columbia; Department of Human Science, School of Nursing and Health Studies, Georgetown University, Washington, District of Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339539PMC
March 2015

Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group.

PLoS One 2014 5;9(8):e104378. Epub 2014 Aug 5.

Sarcoma Services, Department of Orthopedic Surgery, University of Utah, Salt Lake City, Utah, United States of America; Center for Children's Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States of America; Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, Utah, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0104378PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122435PMC
November 2015

Reply to G. Mangili et al and C. Lhommé et al.

J Clin Oncol 2014 Sep 28;32(25):2816-7. Epub 2014 Jul 28.

Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.3890DOI Listing
September 2014

Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB).

Am J Med Genet A 2014 Sep 16;164A(9):2250-5. Epub 2014 Jun 16.

Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.36638DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134712PMC
September 2014

The Children's Oncology Group Childhood Cancer Research Network (CCRN): case catchment in the United States.

Cancer 2014 Oct 29;120(19):3007-15. Epub 2014 May 29.

Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28813DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287245PMC
October 2014

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.

Pediatr Blood Cancer 2014 Sep 22;61(9):1558-64. Epub 2014 Apr 22.

Department of Pediatrics, The Children's Hospital at Montefiore and the Albert Einstein College of Medicine, Bronx, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288578PMC
September 2014

Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.

J Clin Oncol 2014 Feb 6;32(5):465-70. Epub 2014 Jan 6.

Deborah F. Billmire and Frederick J. Rescorla, Riley Hospital for Children, Indianapolis, IN; John W. Cullen, Rocky Mountain Hospital for Children-Presbyterian St Luke's Medical, Denver, CO; Mary Davis and Marc G. Schlatter, Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, MI; Thomas A. Olson, Children's Healthcare of Atlanta, Emory University, Atlanta, GA; Marcio H. Malogolowkin, Children's Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI; Farzana Pashankar, Yale University, New Haven, CT; Doojduen Villaluna, Children's Oncology Group, Monrovia; Mark Krailo, Keck School of Medicine, University of Southern California, Los Angeles, CA; Rachel A. Egler, Rainbow Babies and Children's Hospital, Cleveland, OH; and Carlos Rodriguez-Galindo and A. Lindsay Frazier, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.1006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876316PMC
February 2014

Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study.

Pediatr Blood Cancer 2014 Apr 31;61(4):749-52. Epub 2013 Oct 31.

Department of Pediatrics, Division of Pediatric Hematology/Oncology, Vanderbilt University, Nashville, TN, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24778DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946315PMC
April 2014

Response to "High BMI at diagnosis is associated with inferior survival in patients with osteosarcoma".

Pediatr Blood Cancer 2014 May 11;61(5):951. Epub 2013 Oct 11.

Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24816DOI Listing
May 2014

Parental tobacco and alcohol use and risk of hepatoblastoma in offspring: a report from the children's oncology group.

Cancer Epidemiol Biomarkers Prev 2013 Oct 15;22(10):1837-43. Epub 2013 Aug 15.

Authors' Affiliations: The Brown School, Washington University in St. Louis; Department of Pediatrics, School of Medicine, Siteman Cancer Center, Washington University in St. Louis, St. Louis, Missouri; Division of Epidemiology/Clinical Research, Department of Pediatrics and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota; University of Southern California, Los Angeles, California; University of Texas Health Sciences Center San Antonio, San Antonio, Texas; Children's Hospital of Wisconsin, Milwaukee, Wisconsin; and Children's Hospital & Research Center of Oakland, Oakland, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188411PMC
October 2013

Outcomes for patients with congenital hepatoblastoma.

Pediatr Blood Cancer 2013 Nov 24;60(11):1817-25. Epub 2013 Jun 24.

Sacred Heart Children's Hospital, Spokane, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24655DOI Listing
November 2013